Physician Assistant Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Brittany Scurto

Physician Assistant Park Ridge, IL Physician Assistant

NPI 1477699254 CMS profile 10787900

1550 N Northwest Hwy Ste 300, Park Ridge, IL 60068

Open in the dashboard

General payments

$13,676

385 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Brittany Scurto of Park Ridge, IL is reported in the CMS Open Payments database as having received $13,676 across 385 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $3,943 68
2023 General $3,818 128
2022 General $2,101 73
2021 General $3,814 116

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brittany Scurto
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Brittany Scurto were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Brittany Scurto Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $3,814 $132 $37–$438 $132
2022 $2,101 $155 $48–$522 $149
2023 $3,818 $167 $52–$557 $160
2024 $3,943 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. AbbVie, Inc. $1,863 77 payments
  2. Genzyme Corporation $1,529 23 payments
  3. Journey Medical Corporation $1,478 13 payments
  4. Sun Pharmaceutical Industries Inc. $1,439 38 payments
  5. Incyte Corporation $1,108 5 payments
  6. Janssen Biotech, Inc. $851 25 payments
  7. E.R. Squibb & Sons, L.L.C. $816 19 payments
  8. Lilly USA, LLC $596 25 payments
  9. Novartis Pharmaceuticals Corporation $504 19 payments
  10. Galderma Laboratories, L.P. $484 22 payments
  11. Other $3,010 119 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Food and Beverage $10,011 371 payments
  2. Consulting Fee $2,158 3 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,089 3 payments
  4. Education $380 6 payments
  5. Travel and Lodging $38 2 payments
Products named General payments · program years 2021–2024
  1. DUPIXENT $1,633 25 payments
  2. ILUMYA $988 22 payments
  3. SKYRIZI $970 49 payments
  4. TREMFYA $784 23 payments
  5. Ximino $627 5 payments
  6. SOTYKTU $624 17 payments
  7. Accutane $544 5 payments
  8. RINVOQ $522 19 payments
  9. TALTZ $347 21 payments
  10. VTAMA $339 22 payments
  11. Other $5,522 239 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 24 billing codes

Paid by Medicare

$9,978

Medicare's payments for the services billed

Medicare patients

45

Average age 69

Services billed

216

28 women, 17 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 58%
Arthritis 42%
Ischemic heart disease 27%
Diabetes 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 25 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DUPIXENT
  • GENZYME CORPORATION $1,172
  • Regeneron Healthcare Solutions, Inc. $79
$1,251 — —
TREMFYA
  • Janssen Biotech, Inc. $298
$298 — —
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $276
$276 — —
SKYRIZI
  • AbbVie, Inc. $142
$142 — —
Bimzelx
  • UCB, Inc. $142
$142 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 25 in the dashboard with a free account

Records

385 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record